The/DT
interaction/NN
between/IN
gut/NN
microbiome/NN
and/CC
nutrients/NNS
on/IN
development/NN
of/IN
human/JJ
disease/NN
through/IN
epigenetic/JJ
mechanisms/NNS
./.
====================
Early/JJ
environmental/JJ
exposure/NN
is/VBZ
recognized/VBN
as/IN
a/DT
key/JJ
factor/NN
for/IN
long-term/JJ
health/NN
based/VBN
on/IN
the/DT
Developmental/JJ
Origins/NNS
of/IN
Health/NN
and/CC
Disease/NN
hypothesis/NN
./.
====================
It/PRP
considers/VBZ
that/DT
early-life/JJ
nutrition/NN
is/VBZ
now/RB
being/VBG
recognized/VBN
as/IN
a/DT
major/JJ
contributor/NN
that/DT
may/MD
permanently/RB
program/NN
change/NN
of/IN
organ/NN
structure/NN
and/CC
function/NN
toward/IN
the/DT
development/NN
of/IN
diseases/NNS
,/,
in/IN
which/WDT
epigenetic/JJ
mechanisms/NNS
are/VBP
involved/VBN
./.
====================
Recent/JJ
researches/NNS
indicate/VBP
early-life/JJ
environmental/JJ
factors/NNS
modulate/VBP
the/DT
microbiome/NN
development/NN
and/CC
the/DT
microbiome/NN
might/MD
be/VB
mediate/VBP
diet-epigenetic/JJ
interaction/NN
./.
====================
This/DT
review/NN
aims/VBZ
to/TO
define/VB
which/WDT
nutrients/NNS
involve/VBP
microbiome/JJ
development/NN
during/IN
the/DT
critical/JJ
window/NN
of/IN
susceptibility/NN
to/TO
disease/NN
,/,
and/CC
how/WRB
microbiome/NNS
modulation/NN
regulates/VBZ
epigenetic/JJ
changes/NNS
and/CC
influences/VBZ
human/JJ
health/NN
and/CC
future/JJ
prevention/NN
strategies/NNS
./.
====================
In/IN
1986/CD
,/,
David/JJ
Barker/NN
proposed/VBN
the/DT
Developmental/JJ
Origins/NNS
of/IN
Health/NN
and/CC
Disease/NN
(/(
DOHaD/NN
)/)
hypothesis/NN
,/,
denoted/VBN
fetal/JJ
reprogramming/VBG
,/,
that/DT
the/DT
environmental/JJ
stimuli/NNS
such/JJ
as/IN
nutrients/NNS
during/IN
vulnerable/JJ
development/NN
stages/NNS
may/MD
permanently/RB
program/NN
change/NN
of/IN
organ/NN
structure/NN
and/CC
function/NN
of/IN
the/DT
offspring/VBG
toward/IN
the/DT
development/NN
of/IN
non-communicable/JJ
diseases/NNS
[/(
1/CD
]/)
./.
====================
Since/IN
Barker/NN
’/CD
s/NNS
observation/NN
,/,
denoted/VBN
fetal/JJ
programming/VBG
,/,
it/PRP
is/VBZ
widely/RB
recognized/VBN
that/DT
nutrient/JJ
during/IN
pregnancy/NN
and/CC
lactation/NN
is/VBZ
one/CD
of/IN
the/DT
modifiable/JJ
risk/NN
factors/NNS
for/IN
adult/JJ
chronic/JJ
diseases/NNS
including/VBG
diabetes/NNS
and/CC
cardiovascular/JJ
diseases/NNS
[/(
2/CD
]/)
./.
====================
Following/VBG
the/DT
DOHaD/NN
concept/NN
,/,
early-life/JJ
environmental/JJ
factors/NNS
such/JJ
as/IN
nutrients/NNS
may/MD
modulate/VB
the/DT
development/NN
of/IN
the/DT
gut/NN
microbiota/NNS
[/(
3/CD
]/)
./.
====================
It/PRP
is/VBZ
postulated/VBN
that/IN
the/DT
gut/NN
microbiome/NN
can/MD
be/VB
shaped/VBN
by/IN
nutrients/NNS
,/,
which/WDT
induce/VBP
epigenetic/JJ
changes/NNS
prior/JJ
to/TO
fetal/JJ
and/CC
infant/JJ
programming/VBG
of/IN
disease/NN
./.
====================
In/IN
this/DT
review/NN
,/,
we/PRP
describe/VBP
how/WRB
early/JJ
nutrients/NNS
link/NN
microbiome/NN
modulation/NN
and/CC
influence/VBP
the/DT
early/JJ
epigenome/NN
./.
====================
We/PRP
refer/VBP
the/DT
term/NN
“/NN
early-life/JJ
”/CD
to/TO
the/DT
period/NN
from/IN
pregnancy/NN
to/TO
2/CD
years/NNS
of/IN
age/NN
./.
====================
Moreover/RB
,/,
we/PRP
assess/VBP
the/DT
early-life/JJ
gut/NN
microbiome/NN
as/IN
epigenetic/JJ
modifiers/NNS
are/VBP
associated/VBN
with/IN
early-onset/JJ
or/CC
adult/JJ
diseases/NNS
including/VBG
metabolic/JJ
disorders/NNS
./.
====================
In/IN
detail/NN
,/,
section/NN
2/CD
reviews/VBZ
the/DT
regulation/NN
of/IN
epigenetic/JJ
mechanisms/NNS
for/IN
metabolic/JJ
signaling/NN
through/IN
nutrients/NNS
and/CC
their/PRP$
metabolites/NNS
as/IN
epigenetic/JJ
substrates/NNS
or/CC
cofactors/NNS
./.
====================
Section/NN
3/CD
provides/VBZ
several/JJ
early/JJ
environmental/JJ
factors/NNS
that/WDT
may/MD
modulate/VB
early/JJ
microbial/JJ
communities/NNS
./.
====================
Section/NN
4/CD
describes/VBZ
the/DT
effects/NNS
of/IN
each/DT
nutrient/JJ
on/IN
gut/NN
microbiome/NN
changes/NNS
in/IN
early-life/JJ
through/IN
epigenetic/JJ
mechanisms/NNS
and/CC
the/DT
potential/JJ
role/NN
of/IN
the/DT
gut/NN
microbiome/NN
in/IN
adult/JJ
disease/NN
./.
====================
Epigenetic/JJ
changes/NNS
by/IN
environmental/JJ
conditions/NNS
enhance/VBP
cellular/JJ
plasticity/NN
[/(
4/CD
]/)
./.
====================
Genomic/JJ
DNA/NN
is/VBZ
packed/VBN
into/IN
chromatin/NN
with/IN
histone/NN
protein/NN
and/CC
the/DT
changes/NNS
of/IN
chromatin/NN
structure/NN
participate/VBP
in/IN
the/DT
cellular/JJ
processes/NNS
in/IN
response/NN
to/TO
physiological/JJ
signals/NNS
./.
====================
Chromatin/NN
structure/NN
is/VBZ
determined/VBN
by/IN
epigenetic/JJ
modification/NN
resulting/VBG
in/IN
transcription/NN
and/CC
replication/NN
types/NNS
of/IN
machinery/NN
and/CC
therefore/RB
influences/VBZ
biological/JJ
consequences/NNS
[/(
5/CD
]/)
./.
====================
Epigenetic/JJ
changes/NNS
produce/VBP
DNA/NN
,/,
histone/NN
and/CC
chromatin/NN
modifications/NNS
including/VBG
methylation/NN
,/,
acetylation/NN
,/,
phosphorylation/NN
,/,
sumoylation/NN
,/,
and/CC
ubiquitination/NN
with/IN
modifying/VBG
enzymes/NNS
(/(
e.g./FW
,/,
methyltransferases/NNS
)/)
[/(
6/CD
]/)
./.
====================
Non-coding/JJ
RNA/NN
is/VBZ
an/DT
epigenetic/JJ
mark/VBP
that/DT
mediates/VBZ
epigenetic/JJ
modification/NN
by/IN
environmental/JJ
factors/NNS
such/JJ
as/IN
diet/RB
./.
====================
Modification/NN
of/IN
chromatin/NN
architecture/NN
by/IN
epigenetic/JJ
marks/NNS
can/MD
be/VB
heritable/JJ
and/CC
modify/VB
the/DT
risks/NNS
of/IN
disease/NN
in/IN
later/JJ
life/NN
(/(
Table/JJ
1/CD
)/)
[/(
7-17/CD
]/)
./.
====================
Several/JJ
metabolites/NNS
or/CC
cofactors/NNS
of/IN
tricarboxylic/JJ
acid/NN
(/(
TCA/NN
)/)
cycles/NNS
involved/VBN
in/IN
methylation/NN
or/CC
demethylation/NN
of/IN
histone/NN
[/(
18/CD
]/)
./.
====================
The/DT
epigenetic/JJ
modifying/VBG
enzymes/NNS
use/NN
some/DT
energy/NN
metabolites/NNS
in/IN
one-carbon/JJ
metabolism/NN
with/IN
S-adenosyl-methionine/NN
(/(
SAM/NN
)/)
and/CC
TCA/NN
cycles/NNS
./.
====================
SAM/NN
is/VBZ
generated/VBN
through/IN
one-carbon/JJ
metabolism/NN
and/CC
a/DT
key/JJ
factor/NN
for/IN
epigenetic/JJ
processes/NNS
./.
====================
DNA/NN
methylation/NN
requires/VBZ
the/DT
SAM/NN
as/IN
a/DT
methyl/JJ
donor/NN
,/,
while/IN
ten-eleven/CD
translocation/NN
and/CC
Jumonji/NN
C/NN
domain-containing/JJ
proteins-mediated/VBN
demethylation/NN
requires/VBZ
TCA/NN
cycle/NN
metabolite/NN
α-ketoglutarate/VBP
and/CC
Fe2+/JJ
as/IN
a/DT
cofactor/NN
./.
====================
DNA/NN
and/CC
histone/NN
demethylation/NN
have/VBP
the/DT
potential/JJ
to/TO
regulate/VB
diverse/JJ
physiological/JJ
functions/NNS
,/,
including/VBG
metabolic/JJ
signaling/NN
[/(
19/CD
]/)
./.
====================
There/EX
are/VBP
several/JJ
known/JJ
dietary/JJ
methyl/NN
donors/NNS
including/VBG
folate/JJ
,/,
choline/NN
,/,
and/CC
vitamin/NN
B12/NN
participate/VBP
in/IN
one-carbon/JJ
metabolism/NN
and/CC
these/DT
nutrients/NNS
have/VBP
been/VBN
examined/VBN
for/IN
the/DT
epigenetic/JJ
regulation/NN
in/IN
animal/NN
and/CC
human/JJ
studies/NNS
[/(
2/CD
]/)
./.
====================
Methyl/NN
donors/NNS
are/VBP
related/JJ
to/TO
energy/NN
production/NN
and/CC
amino/NN
acid/NN
metabolism/NN
,/,
therefore/RB
nutritional/JJ
imbalance/NN
as/IN
the/DT
disruption/NN
of/IN
the/DT
one-carbon/JJ
cycle/NN
may/MD
participate/VB
in/IN
the/DT
development/NN
of/IN
metabolic/JJ
diseases/NNS
./.
====================
Besides/RB
,/,
many/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
the/DT
mechanism/NN
of/IN
developmental/JJ
reprogramming/VBG
is/VBZ
involved/VBN
in/IN
dietary/JJ
availability/NN
of/IN
methyl/NN
donors/NNS
[/(
2/CD
]/)
./.
====================
Histone/NN
(/(
de/FW
)/)
methylation/NN
is/VBZ
one/CD
of/IN
the/DT
mechanisms/NNS
involved/VBN
in/IN
several/JJ
diseases/NNS
including/VBG
metabolic/JJ
syndrome/NN
and/CC
cancer/NN
[/(
20/CD
]/)
./.
====================
Lysine/NN
methylation/NN
of/IN
a/DT
specific/JJ
site/NN
of/IN
H3/NN
acts/VBZ
both/CC
transcriptional/JJ
activation/NN
(/(
H3K4/NN
)/)
and/CC
silencing/JJ
(/(
H3K9/NN
,/,
H3K27/NN
)/)
for/IN
regulating/VBG
gene/NN
expression/NN
by/IN
a/DT
degree/NN
of/IN
methylation/NN
within/IN
the/DT
histone/NN
tail/NN
./.
====================
The/DT
H3K9/NN
specific/JJ
demethylase/NN
JmjC/NN
domain-containing/JJ
histone/NN
demethylase/NN
2A/NN
(/(
JHDM2A/NN
)/)
was/VBD
well/RB
known/VBN
to/TO
an/DT
important/JJ
regulator/NN
of/IN
fatty/JJ
acid/NN
metabolism/NN
,/,
therefore/RB
loss/NN
of/IN
function/NN
of/IN
JHDM2A/NN
resulted/VBD
in/IN
obesity/NN
and/CC
hyperlipidemia/NN
[/(
21,22/CD
]/)
./.
====================
H3K4/NN
demethylase/VBP
LSD1/NN
using/VBG
flavin/JJ
adenine/NN
dinucleotide/NN
(/(
FAD/NN
)/)
as/IN
a/DT
cofactor/NN
,/,
epigenetically/RB
represses/VBZ
energy/NN
expenditure/NN
,/,
which/WDT
facilitates/VBZ
energy/NN
storage/NN
as/IN
triglycerides/NNS
in/IN
white/JJ
adipocytes/NNS
[/(
23/CD
]/)
./.
====================
FAD/NN
is/VBZ
also/RB
related/JJ
to/TO
the/DT
TCA/NN
cycle/NN
,/,
oxidative/JJ
phosphorylation/NN
,/,
and/CC
fatty/JJ
acid/NN
β-oxidation/NN
with/IN
riboflavin/NN
(/(
vitamin/NN
B2/NN
)/)
in/IN
the/DT
cytoplasm/NN
and/CC
mitochondria/NN
[/(
24/CD
]/)
./.
====================
Arginine/NN
methylation/NN
of/IN
histone/NN
has/VBZ
been/VBN
rapidly/RB
highlighted/JJ
over/IN
the/DT
years/NNS
for/IN
the/DT
role/NN
of/IN
diseases/NNS
[/(
9/CD
]/)
./.
====================
Protein/NN
arginine/NN
methyltransferases/NNS
(/(
PRMTs/NNS
)/)
with/IN
SAM/NN
as/IN
a/DT
methyl/JJ
donor/NN
,/,
transfer/NN
of/IN
methyl/JJ
groups/NNS
to/TO
specific/JJ
arginine/NN
residues/NNS
in/IN
histone/NN
and/CC
nonhistone/NN
protein/NN
substrates/NNS
,/,
resulting/VBG
in/IN
the/DT
byproduct/NN
S-adenosyl-homocysteine/NN
(/(
SAH/NN
)/)
./.
====================
The/DT
SAM/SAH/NN
ratio/NN
can/MD
reflect/VB
the/DT
cellular/JJ
methylation/NN
potential/JJ
,/,
which/WDT
interacted/VBD
with/IN
PRMTs/NNS
./.
====================
Peroxisome/NN
proliferator-activated/JJ
receptor/NN
gamma/NN
coactivator/NN
1α/NN
(/(
PGC-1α/NN
;/:
encoded/VBN
by/IN
the/DT
PPARGC1A/NN
)/)
serves/VBZ
as/IN
a/DT
transcriptional/JJ
coactivator/NN
in/IN
mitochondria/NN
and/CC
has/VBZ
a/DT
function/NN
in/IN
oxidative/JJ
metabolism/NN
./.
====================
PRMT1/NN
mediated/VBN
cytosine/NN
methylation/NN
in/IN
PGC-1α/NN
which/WDT
is/VBZ
expressed/VBN
in/IN
brown/JJ
adipose/NN
tissue/NN
involved/VBN
in/IN
energy/NN
metabolism/NN
and/CC
diabetes/VBZ
[/(
25/CD
]/)
./.
====================
Acetylation/NN
of/IN
histone/NN
H3/NN
and/CC
H4/NN
is/VBZ
mediated/VBN
by/IN
acetyl-CoA/NN
and/CC
NAD+/NN
for/IN
cellular/JJ
metabolism/NN
./.
====================
Lysine/NN
acetylation/NN
occurs/VBZ
in/IN
proteins/NNS
involved/VBN
in/IN
glycolysis/NN
,/,
pyruvate/NN
metabolism/NN
and/CC
the/DT
TCA/NN
cycle/NN
[/(
26/CD
]/)
./.
====================
Sirtuin/NN
1/CD
(/(
SIRT1/NN
)/)
,/,
a/DT
deacetylase/NN
depending/VBG
on/IN
NAD+/NN
has/VBZ
emerged/VBN
as/IN
a/DT
key/JJ
metabolic/JJ
sensor/NN
linking/VBG
to/TO
metabolic/JJ
homeostasis/NN
,/,
and/CC
SIRT1/NN
participates/VBZ
the/DT
regulation/NN
of/IN
glucose/NN
homeostasis/NN
under/IN
nutrient/JJ
deficiency/NN
[/(
27/CD
]/)
./.
====================
For/IN
example/NN
,/,
SIRT1/NN
modulates/VBZ
acetylation/NN
on/IN
H3K9/K14/NN
at/IN
circadian/JJ
clock-controlled/VBN
gene/NN
promoters/NNS
through/IN
a/DT
high-fat/JJ
diet/VBP
[/(
28/CD
]/)
./.
====================
It/PRP
is/VBZ
reported/VBN
that/IN
acetyl-CoA/NN
dependent/JJ
histone/NN
acetylation/NN
may/MD
have/VB
an/DT
important/JJ
role/NN
in/IN
the/DT
cellular/JJ
assessment/NN
of/IN
metabolic/JJ
states/NNS
and/CC
circadian/JJ
clock/NN
[/(
29/CD
]/)
./.
====================
Therefore/RB
,/,
nutrients/NNS
(/(
e.g./FW
,/,
pyruvate/NN
,/,
fatty/JJ
acids/NNS
,/,
or/CC
branched-chain/NN
amino/NN
acids/NNS
)/)
involved/VBN
in/IN
acetyl-Co/NN
A/NN
levels/NNS
can/MD
modulate/VB
metabolic/JJ
signaling/NN
./.
====================
Nutrients/NNS
driven/VBN
O-GlcNAc/JJ
(/(
N-acetylglucosamine/NN
)/)
glycosylation/NN
has/VBZ
emerged/VBN
as/IN
an/DT
important/JJ
chromatin/NN
modification/NN
process/NN
[/(
30,31/CD
]/)
./.
====================
O-GlcNAc/JJ
transferase/NN
(/(
OGT/NN
)/)
is/VBZ
a/DT
key/JJ
enzyme/NN
through/IN
protein/NN
glycosylation/NN
in/IN
the/DT
Hexosamone/NN
Biosynthetic/JJ
Pathway/NN
./.
====================
Several/JJ
studies/NNS
reported/VBD
that/IN
nutrients-sensing/VBG
GlcNAcylation/NN
of/IN
histone/NN
proteins/NNS
has/VBZ
involved/VBN
in/IN
chromatin/NN
remodeling/NN
and/CC
regulation/NN
of/IN
biological/JJ
processes/NNS
[/(
32/CD
]/)
./.
====================
Chromatin/NN
GlcNAcylation/NN
depend/VBP
on/IN
the/DT
cellular/JJ
processes/NNS
with/IN
glucose/NN
,/,
glutamine/NN
,/,
fatty/JJ
acid/NN
and/CC
ATP/NN
metabolism/NN
./.
====================
High/JJ
fat/NN
diet/VBP
induced/VBD
insulin/NN
resistance/NN
,/,
hyperphagia/NN
and/CC
obesity/NN
through/IN
O-GlcNAc/JJ
cycling/NN
[/(
33,34/CD
]/)
;/:
thus/RB
,/,
OGT/NN
can/MD
be/VB
a/DT
sensor/NN
for/IN
adipose/JJ
to/TO
brain/VB
axis/NN
to/TO
target/NN
obesity/NN
[/(
34/CD
]/)
./.
====================
The/DT
early-life/JJ
microbiota/NNS
contains/VBZ
a/DT
unique/JJ
microbial/JJ
communities/NNS
consisting/VBG
of/IN
numerous/JJ
bacteria/NNS
and/CC
viruses/NNS
./.
====================
This/DT
microbiota/NN
has/VBZ
identified/VBN
by/IN
using/VBG
different/JJ
kinds/NNS
of/IN
technologies/NNS
including/VBG
16S/NN
rRNA/NN
sequencing/NN
./.
====================
The/DT
gut/NN
microbiota/NNS
is/VBZ
linked/VBN
to/TO
risk/NN
for/IN
various/JJ
conditions/NNS
in/IN
inflammatory/JJ
diseases/NNS
,/,
asthma/NN
,/,
obesity/NN
,/,
glucose/NN
intolerance/NN
,/,
and/CC
type/NN
2/CD
diabetes/NNS
[/(
35-37/CD
]/)
./.
====================
Over/RB
the/DT
last/JJ
decades/NNS
,/,
the/DT
paradigm/NN
of/IN
a/DT
sterile/JJ
condition/NN
in/IN
utero/FW
is/VBZ
shifting/VBG
to/TO
the/DT
possibility/NN
of/IN
the/DT
prenatal/JJ
maternal-fetal/JJ
coexist/VBP
with/IN
commensal/JJ
and/CC
symbiotic/JJ
microbes/NNS
[/(
38/CD
]/)
./.
====================
Recent/JJ
studies/NNS
also/RB
support/VBP
a/DT
prenatal/JJ
microbial/JJ
milieu/NN
through/IN
bacterial/JJ
presentation/NN
in/IN
placenta/NN
,/,
amniotic/JJ
fluid/NN
,/,
umbilical/JJ
cord/NN
,/,
and/CC
meconium/NN
[/(
39/CD
]/)
./.
====================
In/IN
addition/NN
,/,
there/EX
are/VBP
emerging/VBG
reports/NNS
of/IN
the/DT
prenatal/JJ
microbial/JJ
composition/NN
on/IN
fetal/JJ
and/CC
postnatal/JJ
development/NN
./.
====================
However/RB
,/,
concerns/VBZ
have/VBP
raised/VBN
by/IN
molecular/JJ
based/VBN
approaches/NNS
,/,
therefore/RB
it/PRP
is/VBZ
needed/VBN
for/IN
appropriate/JJ
controls/NNS
to/TO
account/VB
for/IN
DNA/NN
contamination/NN
or/CC
bacterial/JJ
viability/NN
[/(
40/CD
]/)
./.
====================
A/DT
maternal/JJ
condition/NN
during/IN
pregnancy/NN
and/CC
postnatal/JJ
period/NN
can/MD
provide/VB
a/DT
critical/JJ
window/NN
for/IN
susceptibility/NN
to/TO
microbiome/DT
development/NN
through/IN
the/DT
environmental/JJ
factors/NNS
such/JJ
as/IN
mode/NN
of/IN
delivery/NN
and/CC
maternal/JJ
diet/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
The/DT
delivery/NN
mode/NN
has/VBZ
a/DT
crucial/JJ
function/NN
in/IN
the/DT
early/JJ
gut/NN
microbiota/NNS
composition/NN
./.
====================
Infants/NNS
by/IN
vaginally/RB
delivery/NN
have/VBP
higher/JJR
levels/NNS
of/IN
intestinal/JJ
Bacteroides/NNS
,/,
Lactobacilli/NN
,/,
and/CC
Bifidobacterium/NN
,/,
which/WDT
are/VBP
commonly/RB
present/JJ
in/IN
vaginal/JJ
route/NN
,/,
whereas/IN
infants/NNS
by/IN
caesarean/JJ
section/NN
(/(
C-section/NN
)/)
have/VBP
higher/JJR
level/NN
of/IN
Enterococcus/NN
,/,
and/CC
Clostridium/NN
from/IN
skin/NN
,/,
oral/JJ
or/CC
hospital/JJ
environment/NN
[/(
41/CD
]/)
./.
====================
C-section/NN
born/JJ
infants/NNS
have/VBP
shown/VBN
to/TO
an/DT
increased/VBN
risk/NN
of/IN
immune/JJ
disorder/NN
such/JJ
as/IN
asthma/NN
and/CC
allergy/NN
and/CC
obesity/NN
[/(
42,43/CD
]/)
./.
====================
It/PRP
has/VBZ
been/VBN
revealed/VBN
that/IN
neonates/NNS
born/JJ
by/IN
C-section/NN
exhibited/VBD
significantly/RB
higher/JJR
global/JJ
DNA/NN
methylation/NN
levels/NNS
in/IN
leucocytes/NNS
[/(
44/CD
]/)
and/CC
CD34+/JJ
cell/NN
[/(
45/CD
]/)
compared/VBN
with/IN
those/DT
born/VBN
vaginally/RB
./.
====================
Gestational/JJ
age/NN
is/VBZ
another/DT
important/JJ
influencer/NN
for/IN
gut/NN
microbiome/NN
development/NN
[/(
7,8/CD
]/)
./.
====================
It/PRP
was/VBD
reported/VBN
that/IN
the/DT
gut/NN
microbiota/NNS
of/IN
preterm/JJ
infants/NNS
has/VBZ
shown/VBN
to/TO
delayed/VBN
colonization/NN
by/IN
limited/JJ
microbial/JJ
diversity/NN
and/CC
ths/NNS
risk/NN
of/IN
gut/NN
dysbiasis/NN
./.
====================
The/DT
gut/NN
microbiota/NNS
composition/NN
of/IN
preterm/JJ
infants/NNS
has/VBZ
Enterobacter/NN
,/,
Enterococcus/NN
,/,
Escherichia/FW
,/,
and/CC
Klebsiella/NN
predominantly/RB
and/CC
relatively/RB
low/JJ
level/NN
of/IN
gammaproteobacteria/NN
than/IN
those/DT
in/IN
full/JJ
term/NN
infants/NNS
[/(
46/CD
]/)
./.
====================
Breastfeeding/VBG
have/VBP
been/VBN
reported/VBN
to/TO
influence/VB
the/DT
infant/JJ
microbiota/NNS
./.
====================
It/PRP
was/VBD
reported/VBN
that/IN
microbiome/VBP
involved/VBN
the/DT
effects/NNS
of/IN
DNA/NN
methylation/NN
through/IN
breast/NN
milk/NN
,/,
which/WDT
influences/VBZ
the/DT
gut/NN
microbiome/NN
community/NN
composition/NN
./.
====================
Breastfeeding/VBG
during/IN
this/DT
period/NN
is/VBZ
associated/VBN
with/IN
greater/JJR
Bacteroides/NNS
and/CC
Bifidobacterium/NN
,/,
which/WDT
are/VBP
folate/JJ
producers/NNS
,/,
thereby/RB
affecting/VBG
DNA/NN
methylation/NN
regulated/VBN
by/IN
methyl-donor/JJ
[/(
47/CD
]/)
./.
====================
Also/RB
,/,
breast/NN
milk/NN
oligosaccharides/NNS
alter/VBP
hut/JJ
microbiome/NN
community/NN
that/DT
secrete/VBP
short-chain/JJ
fatty/JJ
acid/NN
./.
====================
Therefore/RB
,/,
the/DT
strain/NN
of/IN
Bifidobacterium/NN
and/CC
Lactobacillus/NN
by/IN
breastfeeding/VBG
could/MD
make/VB
intestinal/JJ
contents/NNS
more/RBR
acidic/JJ
with/IN
short-chain/JJ
fatty/JJ
acids/NNS
,/,
which/WDT
modulate/VBP
a/DT
defense/JJ
mechanism/NN
against/IN
pathogens/NNS
and/CC
epigenetic/JJ
effects/NNS
[/(
48/CD
]/)
./.
====================
As/IN
mentioned/VBN
above/JJ
,/,
early/JJ
environmental/JJ
factors/NNS
such/JJ
as/IN
nutrition/NN
may/MD
have/VB
interacted/VBN
with/IN
gut/NN
microbiome/NN
./.
====================
Also/RB
,/,
the/DT
microbial/JJ
metabolites/NNS
such/JJ
as/IN
B/NN
vitamins/NNS
,/,
short/JJ
chain/NN
fatty/JJ
acids/NNS
(/(
SCFAs/NNS
)/)
,/,
polyphenols/NNS
(/(
ellagic/JJ
acid/NN
,/,
urolithin/IN
,/,
equol/JJ
,/,
isothiocyanate/VBP
)/)
,/,
and/CC
omega3/NN
polyunsaturated/JJ
fatty/JJ
acid/NN
(/(
PUFA/NN
)/)
are/VBP
reported/VBN
to/TO
influence/VB
epigenetic/JJ
mechanisms/NNS
[/(
49,50/CD
]/)
./.
====================
Maternal/JJ
gut/NN
microbe/NN
metabolites/NNS
can/MD
change/VB
the/DT
host/NN
cellular/JJ
levels/NNS
of/IN
important/JJ
epigenetic/JJ
modifiers/NNS
like/IN
histone/NN
acetyl/NN
transferases/VBZ
(/(
HATs/NNS
)/)
,/,
histone/NN
deacetylases/NNS
(/(
HDACs/NNS
)/)
,/,
DNA/NN
methyltransferases/NNS
(/(
DNMTs/NNS
)/)
,/,
and/CC
DNA/NN
demethylases/VBZ
[/(
51/CD
]/)
./.
====================
A/DT
number/NN
of/IN
the/DT
vitamins/NNS
can/MD
not/RB
be/VB
synthesized/VBN
by/IN
the/DT
human/JJ
body/NN
,/,
therefore/RB
must/MD
be/VB
obtained/VBN
by/IN
the/DT
diet/NN
./.
====================
The/DT
gut/NN
microbiome/NN
is/VBZ
one/CD
of/IN
the/DT
important/JJ
sources/NNS
of/IN
B/NN
vitamins/NNS
for/IN
the/DT
host/NN
[/(
52/CD
]/)
./.
====================
Vitamins/NNS
B2/NN
,/,
B6/NN
,/,
B9/NN
,/,
and/CC
B12/NN
are/VBP
important/JJ
cofactors/NNS
for/IN
the/DT
enzymes/NNS
in/IN
the/DT
folate/JJ
cycle/NN
where/WRB
the/DT
conversion/NN
from/IN
homocysteine/NN
to/TO
methionine/JJ
is/VBZ
required/VBN
for/IN
the/DT
availability/NN
of/IN
SAM/NN
./.
====================
Therefore/RB
,/,
these/DT
vitamins/NNS
could/MD
affect/VB
histone/NN
methyl/NN
transferasess/VBP
and/CC
DNMTs/NNS
for/IN
histone/NN
and/CC
DNA/NN
methylation/NN
./.
====================
The/DT
other/JJ
gut/NN
microbial/JJ
metabolites/NNS
such/JJ
as/IN
vitamins/NNS
B3/NN
,/,
B5/NN
,/,
and/CC
SCFAs/NNS
are/VBP
sources/NNS
of/IN
acetyl-CoA/NN
or/CC
NAD/NN
,/,
which/WDT
affect/VBP
histone/NN
acetylation/NN
via/IN
sirtuin/JJ
inhibition/NN
or/CC
HAT/NN
activation/NN
[/(
51/CD
]/)
./.
====================
The/DT
microbial/JJ
SCFAs/NNS
from/IN
the/DT
fermentation/NN
of/IN
dietary/JJ
fiber/NN
were/VBD
shown/VBN
to/TO
maintain/VB
the/DT
nervous/JJ
and/CC
immune/JJ
systems/NNS
through/IN
epigenetic/JJ
modification/NN
[/(
17,53/CD
]/)
./.
====================
The/DT
SCFA/NN
acetate/NN
and/CC
butyrate/NN
are/VBP
the/DT
most/JJS
abundant/JJ
in/IN
the/DT
intestinal/JJ
tract/NN
and/CC
can/MD
be/VB
produced/VBN
with/IN
acetyl-CoA/NN
which/WDT
is/VBZ
universal/JJ
acetyl/NN
group/NN
donor/NN
for/IN
histone/NN
acetylation/NN
./.
====================
Maternal/JJ
acetate/NN
suppressed/VBD
asthma/NN
by/IN
Treg/NN
and/CC
Foxp3/NN
through/IN
HDAC9/NN
inhibition/NN
[/(
54/CD
]/)
./.
====================
Besides/RB
,/,
the/DT
SCFA/NN
butyrate/NN
induced/VBD
global/JJ
histone/NN
acetylation/NN
and/CC
activation/NN
in/IN
FOXO3A/NN
and/CC
MT2/NN
by/IN
inhibiting/VBG
HDAC1/NN
and/CC
HDAC2/NN
[/(
55/CD
]/)
./.
====================
The/DT
SCFA/NN
pentanoate/NN
produced/VBN
by/IN
gut/NN
microbiota/NNS
such/JJ
as/IN
Bacteroides/NNS
,/,
Bifidobacterium/NN
,/,
and/CC
Lactobacillus/NN
affects/VBZ
the/DT
use/NN
of/IN
the/DT
acetyl-CoA/NN
pool/NN
for/IN
histone/NN
acetylation/NN
[/(
56/CD
]/)
that/IN
inhibits/VBZ
HDAC1/NN
and/CC
HDAC8/NN
in/IN
CD4+/JJ
T/NN
cell/NN
,/,
thereby/RB
reduce/VBP
interleukin/NN
(/(
IL/NN
)/)
-17A/CD
production/NN
and/CC
enhance/VBP
IL-10/NN
production/NN
[/(
56/CD
]/)
./.
====================
Polyphenols/NNS
have/VBP
antioxidant/JJ
,/,
anti-inflammatory/JJ
,/,
and/CC
immune-modulatory/JJ
effects/NNS
./.
====================
Maternal/JJ
supplementation/NN
of/IN
polyphenols/NNS
improved/VBD
the/DT
early/JJ
development/NN
of/IN
the/DT
risk/NN
of/IN
intrauterine/JJ
growth/NN
restriction/NN
[/(
57/CD
]/)
./.
====================
Urolithins/NNS
are/VBP
microbial/JJ
metabolites/NNS
from/IN
ellagic/JJ
acid/NN
(/(
one/CD
of/IN
the/DT
polyphenols/NNS
)/)
that/WDT
are/VBP
reported/VBN
to/TO
have/VB
a/DT
protective/JJ
effect/NN
on/IN
chronic/JJ
diseases/NNS
such/JJ
as/IN
metabolic/JJ
syndrome/NN
[/(
58/CD
]/)
and/CC
decrease/NN
triglyceride/NN
accumulation/NN
in/IN
adipocytes/NNS
[/(
14/CD
]/)
./.
====================
Ellagic/JJ
acid/NN
was/VBD
reported/VBN
to/TO
inhibit/VB
reduction/NN
of/IN
HDAC/NN
activity/NN
and/CC
urolithins/NNS
prevented/VBD
HAT/NN
activity/NN
[/(
15/CD
]/)
./.
====================
Recent/JJ
studies/NNS
were/VBD
shown/VBN
that/IN
urolithin/NN
bacteria/NNS
are/VBP
Bifidobacterium/NN
,/,
pseudocatenulatum/NN
,/,
Lactobacilli/NN
,/,
and/CC
Coriobacteriaceae/NN
(/(
Gordonibacter/NNP
)/)
[/(
59/CD
]/)
and/CC
Eggerthellaceae/NN
family/NN
[/(
60/CD
]/)
./.
====================
Equol/NN
produced/VBN
by/IN
the/DT
intestinal/JJ
bacterium/NN
Lactococcus/NN
reduced/VBD
the/DT
risk/NN
of/IN
cardiovascular/JJ
diseases/NNS
including/VBG
low-density/JJ
lipoprotein/NN
cholesterol/NN
and/CC
arterial/JJ
stiffness/RB
[/(
61/CD
]/)
./.
====================
Omega-3/NN
PUFAs/NNS
are/VBP
also/RB
obtained/VBN
by/IN
the/DT
diet/NN
and/CC
have/VBP
been/VBN
interacted/VBN
with/IN
gut/NN
microbiota/NNS
./.
====================
Maternal/JJ
omega-3/NN
PUFAs/NNS
are/VBP
a/DT
key/JJ
role/NN
in/IN
the/DT
immune/JJ
system/NN
of/IN
the/DT
infant/JJ
through/IN
the/DT
epigenetic/JJ
mechanism/NN
for/IN
DNA/NN
and/CC
histone/NN
methylation/NN
[/(
11,62/CD
]/)
./.
====================
For/IN
the/DT
epigenetic/JJ
mechanism/NN
,/,
it/PRP
was/VBD
reported/VBN
that/IN
maternal/JJ
omega-3/NN
PUFA/NN
induced/VBD
changing/VBG
of/IN
methylation/NN
level/NN
in/IN
differentially/RB
methylated/VBN
regions/NNS
[/(
12/CD
]/)
and/CC
the/DT
promoter/NN
methylation/NN
level/NN
of/IN
Interferon/NN
γ/RB
and/CC
IL13/NN
[/(
62/CD
]/)
./.
====================
Maternal/JJ
omega-3/NN
PUFAs/NNS
regulated/VBN
offspring/VBG
obesity/NN
through/IN
recomposition/NN
of/IN
the/DT
gut/NN
microbiota/NNS
,/,
Epsilonproteobacteria/JJ
,/,
Bacteroides/NNS
,/,
Akkermansia/NN
,/,
and/CC
Clostridia/NN
[/(
63/CD
]/)
./.
====================
High-/JJ
fat/NN
diet/NN
promotes/VBZ
intestinal/JJ
epithelial/JJ
HDAC3/NN
level/NN
and/CC
SCFA/NN
butylate/CC
supplementation/NN
reduced/VBD
HDAC3/NN
activity/NN
[/(
64/CD
]/)
./.
====================
Similarly/RB
,/,
maternal/JJ
high/JJ
fat/NN
diet/VBP
decreased/VBD
fecal/JJ
SCFA/NN
propionate/NN
and/CC
butylate/CC
level/NN
and/CC
increased/VBD
Firmicutes/NNS
to/TO
Bacteroidetes/NNS
ratio/NN
,/,
Akkermansia/NN
,/,
and/CC
Verrucomicrobia/FW
in/IN
the/DT
offsprings/NNS
related/JJ
to/TO
blood/NN
pressure/NN
[/(
65/CD
]/)
./.
====================
Maternal/JJ
over-nutrition/NN
and/CC
undernutrition/NN
have/VBP
shown/VBN
to/TO
increase/VB
predisposition/NN
to/TO
obesity/NN
and/CC
epigenetic/JJ
changes/NNS
in/IN
offspring/VBG
[/(
2,66/CD
]/)
./.
====================
Such/JJ
maternal/JJ
malnutrition/NN
disrupted/VBN
the/DT
stable/JJ
microbial/JJ
community/NN
,/,
and/CC
less/RBR
bacterial/JJ
richness/NN
and/CC
diversity/NN
,/,
which/WDT
is/VBZ
linked/VBN
to/TO
increased/VBN
risk/NN
of/IN
inflammatory/JJ
diseases/NNS
and/CC
obesity/NN
[/(
67-70/CD
]/)
./.
====================
The/DT
maternal/JJ
high/JJ
fat/NN
diet/RB
was/VBD
associated/VBN
with/IN
alterations/NNS
in/IN
the/DT
gut/NN
microbiome/NNS
profiles/NNS
of/IN
offspring/VBG
for/IN
Coprococcus/NN
,/,
Coriobacteriacae/NNP
,/,
Helicobacterioceae/RB
,/,
and/CC
Allobaculum/FW
[/(
71/CD
]/)
,/,
the/DT
ratio/NN
of/IN
Bacteroidetes/NNS
to/TO
Firmicutes/NNS
[/(
72/CD
]/)
in/IN
mice/NNS
,/,
Campylobacter/NNP
in/IN
Macaca/NN
fuscata/NNS
[/(
13/CD
]/)
and/CC
Bacteroides/NNS
in/IN
humans/NNS
[/(
73/CD
]/)
./.
====================
For/IN
the/DT
epigenetic/JJ
mechanism/NN
,/,
it/PRP
was/VBD
reported/VBN
that/IN
the/DT
high-fat/JJ
diet/VBP
affected/VBN
HNF4ɑ/NN
binding/VBG
sites/NNS
at/IN
acetylated/VBN
histone/NN
H3K27/NN
in/IN
colon/NN
epithelium/NN
[/(
10/CD
]/)
and/CC
decreased/VBD
Bifidobacteriaceae/NN
[/(
74/CD
]/)
./.
====================
Similarly/RB
,/,
over-weighted/VBN
woman/NN
during/IN
pregnancy/NN
had/VBD
higher/JJR
Bacteroids/NNS
and/CC
lower/JJR
Phascolarctobacterium/NN
than/IN
a/DT
normal-weighted/JJ
woman/NN
during/IN
pregnancy/NN
[/(
75/CD
]/)
./.
====================
Under-nutrition/NN
group/NN
in/IN
school-age/NN
children/NN
had/VBD
a/DT
higher/JJR
level/NN
of/IN
the/DT
Firmicutes/NNS
and/CC
Lachnospiraceae/NN
[/(
76/CD
]/)
./.
====================
Besides/RB
,/,
maternal/JJ
supplementation/NN
of/IN
probiotics/NNS
with/IN
Lactobacillus/NN
rhamnousus/NN
or/CC
Bifidobacterium/NN
lactis/NN
induced/VBD
interferon-gamma/NN
production/NN
on/IN
cord/NN
blood/NN
compared/VBN
to/TO
controls/NNS
[/(
77/CD
]/)
./.
====================
The/DT
interaction/NN
between/IN
the/DT
developing/VBG
gut/NN
microbiome/NN
and/CC
epigenetic/JJ
processes/NNS
is/VBZ
an/DT
important/JJ
mechanism/NN
of/IN
developmental/JJ
reprogramming/VBG
of/IN
immune/JJ
disorder/NN
,/,
obesity/NN
,/,
and/CC
metabolic/JJ
disorders/NNS
./.
====================
There/EX
are/VBP
mounting/VBG
evidence/NN
supporting/VBG
that/DT
gut/NN
microbiota/NNS
may/MD
modify/VB
the/DT
pattern/NN
of/IN
DNA/NN
methylation/NN
and/CC
histone/NN
modification/NN
./.
====================
Recent/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
the/DT
gut/NN
microbiome/NN
produces/VBZ
plenty/NN
of/IN
metabolites/NNS
come/NN
from/IN
maternal/JJ
nutrients/NNS
that/DT
have/VBP
the/DT
potential/JJ
to/TO
modulate/VB
DNA/NN
methylation/NN
and/CC
histone/NN
modification/NN
./.
====================
Maternal/JJ
nutrients/NNS
may/MD
have/VB
a/DT
crucial/JJ
role/NN
in/IN
early/JJ
development/NN
and/CC
long/JJ
term/NN
health/NN
consequences/NNS
./.
====================
This/DT
review/NN
explored/VBD
the/DT
impact/NN
of/IN
maternal/JJ
nutrients/NNS
on/IN
epigenetic/JJ
mechanisms/NNS
that/WDT
regulate/VBP
the/DT
early-life/JJ
microbiome/NN
profile/NN
./.
====================
The/DT
importance/NN
of/IN
individual/JJ
nutrients/NNS
induced/VBD
by/IN
epigenetic/JJ
modulation/NN
will/MD
help/VB
achieve/VBP
optimal/JJ
gut/NN
microbiota/NNS
and/CC
strategy/NN
for/IN
improving/VBG
health/NN
consequences/NNS
./.
====================
The/DT
critical/JJ
window/NN
in/IN
early-life/JJ
for/IN
microbiome/NN
modulation/NN
may/MD
influence/VB
on/IN
development/NN
of/IN
diseases/NNS
later/RB
in/IN
life/NN
./.
====================
BMI/NN
,/,
body/NN
mass/NN
index/NN
./.
====================
Epigenetic/JJ
modifications/NNS
and/CC
their/PRP$
functions/NNS
with/IN
nutrients/NNS
====================
